In the latest years, scientific and technical progresses have been made in the study and progress of novel drug delivery systems by overcoming physiological difficulties such as short gastric residence times and unpredictable gastric emptying times. Gastric emptying of dose form is extremely variable process and ability to prolong and control the emptying time. Gastric transit time is valuable asset for dosage forms, which reside in the stomach for a long period of time than conventional dosage form. Several approaches are currently utilized in the prolongation of the gastric residence times, including floating drug delivery systems, swelling and expanding systems, polymeric bioadhesive systems, modified-shape systems, high-density systems and other delayed gastric emptying devices. The purpose of writing this review on floating drug delivery systems (FDDS) was to compile the recent literature with special focus on the principal mechanism of floatation to achieve gastric retention. This review explains briefly about types of floating system, advantages, limitation, floating mechanism, factors affecting floating system, drug candidates suitable for floating, evaluation parameters and application of the system.
Cite this article:
Nikam Aaditya R., Nikum Ashwini C., Shaikh Azam Z.. A Short Review on Floating Drug Delivery System. Asian Journal of Pharmacy and Technology.2022; 12(3):272-6. doi: 10.52711/2231-5713.2022.00044
Nikam Aaditya R., Nikum Ashwini C., Shaikh Azam Z.. A Short Review on Floating Drug Delivery System. Asian Journal of Pharmacy and Technology.2022; 12(3):272-6. doi: 10.52711/2231-5713.2022.00044 Available on: https://ajptonline.com/AbstractView.aspx?PID=2022-12-3-13
1. Hirtz J. The git absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol. 1985;19:77S-83S. PubMed
2. Wlson C. G, Washington N, Physiological Pharmacutics -: Biological Barriers to Drug Absorption, Horwood Ellis, Chichsters, 1989,47-70
3. Singh B.M and Kim K. H., Floating drug delivery systems: an approach to controlled drug delivery via gastric retention. Cont. J. Rel. 2000, 63,235–259.
4. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63:235-259. PubMed DOI: 10.1016/S0168- 3659(99)00204-7
5. Arrora S, Ali J, Khar RK, Baboota S. Floatng drug deli-very systems: A review. AAPS Pharm Sci Tech 2005; 6(3): 372-90.
6. Amit Kumar Nayak, Gastroretentive drug delivery sys-tems: a review, Vol.3 Issue 1, January March 2010, P.no.1-9.
7. Desai S. A Novel Floating Controlled Release Drug Delivery System Based on a Dried Gel Matrix Network [master‟s thesis]. [thesis]. Jamaica, NY: St John‟s University; 1984
8. Simoni P., Cerre C., Cipolla A., et al. Bioavailabilty study of a new sinking, enteric coated ursodeoxycholic acid formulation. Pharmacol. Res. 1995;31:115-119
9. Rubinstein A., Friend D.R, Specific delivery to the gastrointestinal tract, in: Domb A.J (Ed.), Polymeric Site-Specific Pharmacotherapy, Wiley, Chichester, 1994, 282-283.
10. Sheth P.R. and Tossounian J.L. U.S. Patent no.4140755, 1979.
11. Redniek. A.B, Tucker S.J. Sustained release bolus for animal husbandry US Patent 3,507,952, 1970.
12. Umezawa, Hamao United States Patent 4101650.1978
13. Thanoo B.C, Sunny M.C. and Jayakrishnan A., Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid, J. Pharm. Pharmacol. 1993,45,21-24.
14. Washington N., Investigation into the barrier action of an alginate gastric reflux suppressant, Liquid Gaviscon, Drug Investig. 1987,2,23-30
15. KRW, Waugh A. Anatomy and Physiology in Health and Illness. 9th ed. London: Churchill Livingstone; 1996.
16. Babu VBM, Khar RK. In vitro and In vivo studies of sustained release floating dosage forms containing salbutamol sulphate. Pharmazie. 1990; 45: 268-270.
17. Vedhahari b.n.et al, the recent developments on gas-tric floating drug delivery systems: an overview Int. J. Pharmatech Res. 2010,2(1), 524-534.
18. Wu W, Zhou Q, Zhang HB, Ma GD, Fu CD. Studies on nimodipine sustained release tablet capable of floating on gastric fluids with prolonged gastric resident time. Yao XueXue Bao. 1997; 32:786Y790.